Cargando…
Estrogen receptor—positive breast cancer survival prediction and analysis of resistance–related genes introduction
BACKGROUND: In recent years, ER+ and HER2- breast cancer of adjuvant therapy has made great progress, including chemotherapy and endocrine therapy. We found that the responsiveness of breast cancer treatment was related to the prognosis of patients. However, reliable prognostic signatures based on E...
Autores principales: | Shuai, Chen, Yuan, Fengyan, Liu, Yu, Wang, Chengchen, Wang, Jiansong, He, Hongye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555508/ https://www.ncbi.nlm.nih.gov/pubmed/34760348 http://dx.doi.org/10.7717/peerj.12202 |
Ejemplares similares
-
Network-based approach to identify prognosis-related genes in tamoxifen-treated patients with estrogen receptor-positive breast cancer
por: Wang, Yanyan, et al.
Publicado: (2021) -
ERpred: a web server for the prediction of subtype-specific estrogen receptor antagonists
por: Schaduangrat, Nalini, et al.
Publicado: (2021) -
Bioinformatic analysis of cis-regulatory interactions between progesterone and estrogen receptors in breast cancer
por: Khushi, Matloob, et al.
Publicado: (2014) -
Expression of hormone receptors predicts survival and platinum sensitivity of high-grade serous ovarian cancer
por: Tan, Jiahong, et al.
Publicado: (2021) -
Nomogram for predicting cancer specific survival in inflammatory breast carcinoma: a SEER population-based study
por: Zhang, Haige, et al.
Publicado: (2019)